SAN DIEGO (AP) _ Conatus Pharmaceuticals Inc. (CNAT) on Tuesday reported a loss of $656,000 in its second quarter.
On a per-share basis, the San Diego-based company said it had a loss of 2 cents.
The biotechnology company posted revenue of $10.8 million in the period.
In the final minutes of trading on Tuesday, the company's shares hit 31 cents. A year ago, they were trading at $4.04.